Literature DB >> 3881230

Standard therapy for tuberculosis 1985.

D E Snider, D L Cohn, P T Davidson, E S Hershfield, M H Smith, F D Sutton.   

Abstract

Entities:  

Keywords:  Bacterial And Fungal Diseases; Cancer; Child; Diseases; Drugs--administraction and dosage; Drugs--contraindications; Drugs--indications; Hepatic Effects; Infections; Neoplasms; Pregnancy; Renal Effects; Reproduction; Treatment; Tuberculosis--prevention and control; Urogenital Effects

Mesh：

Substances：

Year:  1985        PMID： 3881230     DOI： 10.1378/chest.87.2.117s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

1.  Current concepts in the treatment of tuberculosis.

Authors:  I B Tager
Journal:  West J Med       Date:  1987-04

2.  Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1994-04-15       Impact factor: 8.262

Review 3.  Age-related changes in the manifestations of tuberculosis. Implications for drug therapy.

Authors:  S Umeki
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

4.  Cost-effectiveness of novel first-line treatment regimens for tuberculosis.

Authors:  J P Owens; M O Fofana; D W Dowdy
Journal:  Int J Tuberc Lung Dis       Date:  2013-05       Impact factor: 2.373

5.  Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge.

Authors:  J D Colmenero; M E Jiménez-Mejías; J M Reguera; J Palomino-Nicás; J D Ruiz-Mesa; J Márquez-Rivas; A Lozano; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

6.  Mycobacterial dynamin-like protein IniA mediates membrane fission.

Authors:  Manfu Wang; Xiangyang Guo; Xiuna Yang; Bing Zhang; Jie Ren; Aijun Liu; Yajun Ran; Bing Yan; Fang Chen; Luke W Guddat; Junjie Hu; Jun Li; Zihe Rao
Journal:  Nat Commun       Date:  2019-08-29       Impact factor: 14.919

Review 7.  Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model.

Authors:  Arundhati Maitra; Priya Solanki; Zahra Sadouki; Timothy D McHugh; Frank Kloprogge
Journal:  Antibiotics (Basel)       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.